Ownership history in BAILARD, INC. · 2 quarters on record
This page tracks every 13F SEC filing in which BAILARD, INC. reported a position in MONTE ROSA THERAPEUTICS INC (GLUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 22,500 | — | 0% | 0.00% | $167K | $7.41 |
| 2025 Q2 | INITIATED | 22,500 | — | — | 0.00% | $101K | $4.51 |
As of 2025 Q4 — sorted by position size